While this happened, Deutsche Bank upgraded its Healthpeak Properties Inc [DOC] rating to a Buy from a a Hold in a research note published on October 21, 2024; the price target was increased to $28 from $20. A number of analysts have revised their coverage, including Wedbush’s analysts, who increased its forecast for the stock in early May from “a Neutral” to “an Outperform”. Exane BNP Paribas also remained covering DOC and has increased its forecast on April 26, 2024 with a “an Outperform” recommendation from previously “Neutral” rating.
Price Performance Review of DOC
On Tuesday, Healthpeak Properties Inc [NYSE:DOC] saw its stock fall -0.55% to $19.91. Over the last five days, the stock has lost -0.35%. Healthpeak Properties Inc shares have fallen nearly -1.78% since the year began. Nevertheless, the stocks have risen 1.43% over the past one year. While a 52-week high of $23.26 was reached on 01/03/25, a 52-week low of $16.01 was recorded on 01/07/25. SMA at 50 days reached $21.33, while 200 days put it at $20.70.
Levels Of Support And Resistance For DOC Stock
The 24-hour chart illustrates a support level at 19.77, which if violated will result in even more drops to 19.63. On the upside, there is a resistance level at 20.16. A further resistance level may holdings at 20.40. The Relative Strength Index (RSI) on the 14-day chart is 37.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.21%. Stochastics %K at 29.34% indicates the stock is a holding.
How much short interest is there in Healthpeak Properties Inc?
A steep rise in short interest was recorded in Healthpeak Properties Inc stocks on 2024-12-13, growing by 0.25 million shares to a total of 11.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 10.99 million shares. There was a rise of 2.23%, which implies that there is a positive sentiment for the stock.
